PSW, DRAP launch digital certificates to boost pharmaceutical exportsÂ
Alongside Digital Certificate of Pharmaceutical Product, DRAP Clearance Gateway now offers Free Sale Certificate, Good Manufacturing Practice Certificate, and No Objection Certificate for exports; initiative to enhance regulatory efficiency
Citi Pharma submits offers for acquisition of leading pharma companyÂ
Non-binding offer is part of Citi’s strategic expansion plans to become largest pharma firmÂ
DRAP orders immediate recall of substandard veterinary injection
Zaktyl-20 batch found substandard; authorities warn of therapy failure and drug resistance risks
Searle is lagging the pharmaceutical sector. Its recovery might be just around the corner
The pharmaceutical company has had lackluster numbers in recent times. All that might be about to change
Pharma sector earnings rise 3.1x to Rs24.8bn in 2024, driven by 15% rise in net sales
Net sales reach Rs318bn, gross margins improve to 36%, while finance costs rise to Rs8bn in 2024; deregulation of drug prices boosts profitability.
NAB probes Rs1.25bn embezzlement in KP medicine procurement
Inquiry revealed corruption in medicine procurement, with over Rs4 billion paid to 50 companies, 15 of which received more than Rs3 billion
Haleon Pakistan ships first consignment of Centrum multivitamin to Kenya
Shipment marks Pakistan's growing pharmaceutical exports and opens new international trade avenues.
Panadol costs more now. What has this meant for the pharma industry?
Haleon has benefited from the new drug pricing policy introduced by DRAP and it shows in its financial results
DRAP orders urgent recall of substandard medicines, medical products
Contaminated injections, syrups, and IV cannulas flagged; crackdown launched nationwide
Citi Pharma completes first export to MENA region, targets EUR 10 million in annual global sales
Finalizes EUR 560,000 shipment; aims to expand exports to North America and beyond
Customs seizes smuggled Indian-origin medicines worth Rs10.3bn in Karachi
Investigation launched against two pharmaceutical companies over illegal drug trade
Pharma sector thrives with 21.79% growth amid economic stagnation
Deregulation policy drives record sales, but patients face rising costs
Citi Pharma ventures into direct marketing sector
Company aims to improve medicine accessibility and expand globally
Citi Pharma partners with Mersi Farma to establish advanced API plants in Indonesia
Collaboration to bolster pharmaceutical production and expand nutraceutical market
Despite deregulated prices, Searle swings to a loss
Price increases were not enough to compensate for increases in operating costs, despite a gross profit margin expansion